Molecular Tumor Board
Patients diagnosed with metastatic cancer are offered the opportunity to have a tumor biopsy for extensive molecular testing, including evaluation of protein expression, genetic amplifications, and sequencing of genes commonly associated with cancer.
A Molecular Tumor Board comprehensively evaluates the results of these extensive tests. All new molecular reports are reviewed bi-weekly with the relevant patient medical history, and recommendations are sent to the patient’s physician. Common recommendations include:
- Consideration for an available clinical trial
- Treatment with an approved anti-cancer drug
- Genetic counseling and testing for cancer syndromes
Through the combined insight of clinical research and a multidisciplinary approach for molecular testing review, West Cancer Center patients are offered the opportunity for a greater – and more precise – understanding of their individual tumor.